CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
Titel:
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
Auteur:
Gress, Verena Roussy, Mathieu Boulianne, Luc Bilodeau, Mélanie Cardin, Sophie El-Hachem, Nehme Lisi, Véronique Khakipoor, Banafsheh Rouette, Alexandre Farah, Azer Théret, Louis Aubert, Léo Fatima, Furat Audemard, Éric Thibault, Pierre Bonneil, Éric Chagraoui, Jalila Laramée, Louise Gendron, Patrick Jouan, Loubna Jammali, Safa Paré, Bastien Simpson, Shawn M. Tran, Thai Hoa Duval, Michel Teira, Pierre Bittencourt, Henrique Santiago, Raoul Barabé, Frédéric Sauvageau, Guy Smith, Martin A. Hébert, Josée Roux, Philippe P. Gruber, Tanja A. Lavallée, Vincent-Philippe Wilhelm, Brian T. Cellot, Sonia